Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 226
9
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Community-based Leishmaniasis research in Sri Lanka

Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

Can we make anesthesia for dogs safer with the help of nutrition?

Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

Impact of Soylent Consumption on Human Microbiome Composition

As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based...

Backer Badge Funded